The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis
- PMID: 37592262
- PMCID: PMC10433615
- DOI: 10.1186/s12893-023-02149-6
The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis
Abstract
Background: Esophagectomy is the gold-standard treatment for locally advanced esophageal cancer but has high morbimortality rates. Sarcopenia is a common comorbidity in cancer patients. The exact burden of sarcopenia in esophagectomy outcomes remains unclear. Therefore, this systematic review and meta-analysis were performed to establish the impact of sarcopenia on postoperative outcomes of esophagectomy for cancer.
Methods: We performed a systematic review and meta-analysis comparing sarcopenic with non-sarcopenic patients before esophagectomy for cancer (Registration number: CRD42021270332). An electronic search was conducted on Embase, PubMed, Cochrane, and LILACS, alongside a manual search of the references. The inclusion criteria were cohorts, case series, and clinical trials; adult patients; studies evaluating patients with sarcopenia undergoing esophagectomy or gastroesophagectomy for cancer; and studies that analyze relevant outcomes. The exclusion criteria were letters, editorials, congress abstracts, case reports, reviews, cross-sectional studies, patients undergoing surgery for benign conditions, and animal studies. The meta-analysis was synthesized with forest plots.
Results: The meta-analysis included 40 studies. Sarcopenia was significantly associated with increased postoperative complications (RD: 0.08; 95% CI: 0.02 to 0.14), severe complications (RD: 0.11; 95% CI: 0.04 to 0.19), and pneumonia (RD: 0.13; 95% CI: 0.09 to 0.18). Patients with sarcopenia had a lower probability of survival at a 3-year follow-up (RD: -0.16; 95% CI: -0.23 to -0.10).
Conclusion: Preoperative sarcopenia imposes a higher risk for overall complications and severe complications. Besides, patients with sarcopenia had a lower chance of long-term survival.
Keywords: Esophageal neoplasms; Esophagectomy; Meta-analysis; Sarcopenia; Systematic review.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors have no conflict of interest.
Figures






References
-
- Tomaszek S, Cassivi SD. Esophagectomy for the treatment of esophageal cancer. Gastroenterol Clin North Am. 2009;38(1):169–81. - PubMed
-
- Wang PY, Xu LD, Chen XK, Xu L, Yu YK, Zhang RX, Sun HB, Wu HL, Li Y. Sarcopenia and short-term outcomes after esophagectomy: a meta-analysis. Ann Surg Oncol. 2020;27:3041–51. - PubMed
-
- Evans RP, Singh P, Nepogodiev D, Bundred J, Kamarajah S, Jefferies B, Siaw-Acheampong K, Wanigasooriya K, McKay S, Mohamed I, Whitehouse T. Study protocol for a multicenter prospective cohort study on esophagogastric anastomoses and anastomotic leak (the Oesophago-Gastric anastomosis Audit/OGAA) Dis Esophagus. 2020;33(1):doz007. - PubMed
-
- Schmidt HM, Gisbertz SS, Moons J, Rouvelas I, Kauppi J, Brown A, Asti E, Luyer M, Lagarde SM, Berlth F, Philippron A, Bruns C, Hölscher A, Schneider PM, Raptis DA, van Berge Henegouwen MI, Nafteux P, Nilsson M, Räsanen J, Palazzo F, Rosato E, Mercer S, Bonavina L, Nieuwenhuijzen G, Wijnhoven PL, Schröder W, Pattyn P, Grimminger PP, Gutschow CA. Defining benchmarks for Transthoracic Esophagectomy: a Multicenter analysis of total minimally invasive esophagectomy in low risk patients. Ann Surg. 2017;266(5):814–21. doi: 10.1097/SLA.0000000000002445. - DOI - PubMed
-
- Huddy JR, Huddy FM, Markar SR, Tucker O. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer—a narrative review. Dis Esophagus. 2018;31(1):dox110. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous